Blood exosomes from patients with pancreatic cancer (n=24), pancreatitis (n=29) and other cancers (n=20) were analyzed by flow cytometry for exosomal GPC1 and CD82 and serum CA19-9. This evidence concerns the gene GPC1 and pancreatic neoplasm.